Ravaud A - Search Results

1

Metronomic chemotherapy for renal cancer in the landscape of targeted therapy.

Ravaud A, Grossgoupil M. Ravaud A, et al. Lancet Oncol. 2010 Apr;11(4):307-8. doi: 10.1016/S1470-2045(10)70043-7. Lancet Oncol. 2010. PMID: 20359658 No abstract available.

2

Efficacy of re-challenging metastatic renal cell carcinoma with mTOR inhibitors.

Roca S, Quivy A, Gross-Goupil M, Bernhard JC, De Clermont H, Ravaud A. Roca S, et al. Among authors: ravaud a. Acta Oncol. 2011 Oct;50(7):1135-6. doi: 10.3109/0284186X.2011.592149. Epub 2011 Jul 5. Acta Oncol. 2011. PMID: 21726178 No abstract available.

3

Targeted therapies in metastatic renal cell carcinoma: overview of the past year.

Gross-Goupil M, Massard C, Ravaud A. Gross-Goupil M, et al. Among authors: ravaud a. Curr Urol Rep. 2012 Feb;13(1):16-23. doi: 10.1007/s11934-011-0232-y. Curr Urol Rep. 2012. PMID: 22139625 Review.

4

Overcoming resistance to tyrosine kinase inhibitors in renal cell carcinoma.

Ravaud A, Gross-Goupil M. Ravaud A, et al. Cancer Treat Rev. 2012 Dec;38(8):996-1003. doi: 10.1016/j.ctrv.2012.01.003. Epub 2012 Feb 12. Cancer Treat Rev. 2012. PMID: 22330762 Review.

5

[Strategy in advanced castration-resistant prostate cancer].

Gross-Goupil M, Roca S, Pasticier G, Ravaud A. Gross-Goupil M, et al. Among authors: ravaud a. Bull Cancer. 2012 Jul;99 Suppl 1:S37-45. doi: 10.1684/bdc.2012.1562. Bull Cancer. 2012. PMID: 22522582 Review. French.

6

Lapatinib and renal cell carcinoma.

Gross-Goupil M, Bernhard JC, Ravaud A. Gross-Goupil M, et al. Among authors: ravaud a. Expert Opin Investig Drugs. 2012 Nov;21(11):1727-32. doi: 10.1517/13543784.2012.713935. Epub 2012 Aug 9. Expert Opin Investig Drugs. 2012. PMID: 22876762 Review.

7

Prolonged efficacy of mTOR inhibitors in papillary renal cell carcinoma: progression-free survival lasting for over 3 years, a case report and review of the literature.

Daste A, Gross-Goupil M, Roca S, Bernhard JC, Ravaud A. Daste A, et al. Among authors: ravaud a. Target Oncol. 2014 Mar;9(1):81-4. doi: 10.1007/s11523-012-0245-6. Epub 2013 Jan 3. Target Oncol. 2014. PMID: 23283668 Review.

8

Optimal management of renal cell carcinoma in the elderly: a review.

Quivy A, Daste A, Harbaoui A, Duc S, Bernhard JC, Gross-Goupil M, Ravaud A. Quivy A, et al. Among authors: ravaud a. Clin Interv Aging. 2013;8:433-42. doi: 10.2147/CIA.S30765. Epub 2013 Apr 19. Clin Interv Aging. 2013. PMID: 23626463 Free PMC article. Review.

9

Combination therapy in metastatic renal cell cancer.

Ravaud A, Gross-Goupil M, Bellmunt J. Ravaud A, et al. Semin Oncol. 2013 Aug;40(4):472-81. doi: 10.1053/j.seminoncol.2013.05.010. Semin Oncol. 2013. PMID: 23972711 Review.

10

Axitinib: a review of its safety and efficacy in the treatment of adults with advanced renal cell carcinoma.

Gross-Goupil M, François L, Quivy A, Ravaud A. Gross-Goupil M, et al. Among authors: ravaud a. Clin Med Insights Oncol. 2013 Oct 29;7:269-77. doi: 10.4137/CMO.S10594. Clin Med Insights Oncol. 2013. PMID: 24250243 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

331 results

Search Page

Filters